MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 31 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $134,000 | -8.2% | 48,000 | 0.0% | 0.00% | – |
| Q4 2018 | $146,000 | -45.5% | 48,000 | 0.0% | 0.00% | – |
| Q3 2018 | $268,000 | -13.0% | 48,000 | 0.0% | 0.00% | – |
| Q2 2018 | $308,000 | +25.7% | 48,000 | +37.5% | 0.00% | – |
| Q1 2018 | $245,000 | +9.9% | 34,900 | +63.8% | 0.00% | – |
| Q4 2017 | $223,000 | +14.4% | 21,300 | 0.0% | 0.00% | – |
| Q3 2017 | $195,000 | -29.3% | 21,300 | 0.0% | 0.00% | – |
| Q2 2017 | $276,000 | – | 21,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 30,497 | $502,000 | 0.04% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 33,333 | $548,000 | 0.01% |